These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10457414)

  • 1. Immunosuppression due to MACOP-B does not seem to cure the antiphospholipid syndrome.
    Stefani PM; Pietrogrande F; Sartori R; Girolami A
    Haematologica; 1999 Aug; 84(8):751-2. PubMed ID: 10457414
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
    Taillan B; Ferrari E; Garnier G; Fuzibet JG; Vinti H; Dujardin P
    Presse Med; 1992 Feb; 21(6):269. PubMed ID: 1372976
    [No Abstract]   [Full Text] [Related]  

  • 5. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis.
    Martelli MP; Martelli M; Pescarmona E; De Sanctis V; Donato V; Palombi F; Todisco E; Rendina EA; Pau FM; Mandelli F
    Ann Oncol; 1998 Sep; 9(9):1027-9. PubMed ID: 9818079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of different chemotherapy programs, indications for surgery and radiotherapy in primary mediastinal B-cell lymphosarcoma].
    Dzhumabaeva BT; Kremenetskaia AM; Gotman LN; Shavlokhov VS; Kaplanskaia IB; Kravchenko SK; Vishnevskaia ES; Gemdzhian EG; Frank GA
    Ter Arkh; 2005; 77(8):78-81. PubMed ID: 16206611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.
    Takács I; Eros N; Bene I; Bozsó F; Tordai L; Károlyi Z; Radványi G; Matolcsy A
    Ann Hematol; 2004 Sep; 83(9):608-10. PubMed ID: 15205915
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients.
    Casadei B; Argnani L; Morigi A; Lolli G; Broccoli A; Pellegrini C; Nanni L; Stefoni V; Coppola PE; Carella M; Cavo M; Zinzani PL
    Ann Hematol; 2021 Sep; 100(9):2261-2268. PubMed ID: 33305333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gall bladder perforation in response to chemotherapy in a patient with a histiocytic lymphoma.
    Schaafsma MR; Peters WG; Tham RT; Alleman MJ; Willemze R
    Neth J Med; 1988 Aug; 33(1-2):78-82. PubMed ID: 2469970
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical problems in patients with malignancy: case 2. Wernicke's encephalopathy: an unusual acute neurologic complication of lymphoma and its therapy.
    Turner JE; Alley JG; Sharpless NE
    J Clin Oncol; 2004 Oct; 22(19):4020-2. PubMed ID: 15459227
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
    Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpectedly high toxicity of MACOP-B in young patients with low grade lymphoma.
    Arranz R; Pérez G; Steegmann JL; Cámara R; Tomás JF; Figuera A; Vazquez L; Fernández-Rañada JM
    Am J Hematol; 1991 Sep; 38(1):75-6. PubMed ID: 1716853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
    Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
    Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to improve the efficacy of R-CHOP for indolent B-cell lymphoma?].
    Tobinai K
    Rinsho Ketsueki; 2012 Jun; 53(6):609-17. PubMed ID: 22790636
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
    Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
    Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive sclerodermoid skin changes--quiz case.
    Dacso MM; Petitt MS; Berlingeri-Ramos AC; Kelly BC
    Arch Dermatol; 2012 Feb; 148(2):247-52. PubMed ID: 22351831
    [No Abstract]   [Full Text] [Related]  

  • 18. Unusual lymphoma manifestations: case 2. Myocardial lymphoma presenting as atrial flutter.
    Thompson MA; Harker-Murray A; Locketz AJ; Chareonthaitawee P
    J Clin Oncol; 2004 Feb; 22(3):558-60. PubMed ID: 14752079
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete remission by chemotherapy in stage IE-IIE primary gastric lymphoma.
    Kochi M; Fujii M; Kanamori N; Kaiga T; Takahashi T; Kobayashi M; Takayama T
    Hepatogastroenterology; 2007 Jun; 54(76):1285-8. PubMed ID: 17629090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.